Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis

NCT02744755 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Adalimumab - GP2017
BIOLOGICAL: Adalimumab - US licensed Humira

Sponsor

Sandoz

Collaborators

[object Object]